1 completed, 1 terminated, 1 withdrawn. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Completed 1, Terminated 1, Withdrawn 1 |
Follow High Cholesterol: new trials by email Literature Review of High Cholesterol trials Research Report on High Cholesterol
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Evolocumab In Advanced Chronic Kidney Disease Trial Evolocumab, Placebo - Chronic Kidney Diseases, High Cholesterol | Phase 4 | Withdrawn | NYU Langone Health | 2021-03-01 | 2022-07-28 | |
| Additive Effects of Pravastatin and Valsartan pravastatin, valsartan, pravastatin+valsartan - Hypertension, High Cholesterol | Phase 4 | Completed | Gachon University Gil Medical Center | 52 | 2009-11-01 | 2012-08-09 |
| The Effect of Atorvastatin on Endothelial Cell Dysfunction in Chronic Kidney Disease Atorvastatin - Chronic Kidney Disease, High Cholesterol | Phase 4 | Terminated | Duke University | 1 | 2008-02-01 | 2014-07-03 |
Hypercholesterolemia (3) · Renal Insufficiency, Chronic (2) · Hypertension (1) · Insulin Resistance (1)
Dyslipidemias (3) · Hyperlipidemias (3) · Lipid Metabolism Disorders (3) · Metabolic Diseases (3) · Nutritional and Metabolic Diseases (3) · Chronic Disease (2) · Disease Attributes (2) · Female Urogenital Diseases (2) · Female Urogenital Diseases and Pregnancy Complications (2) · Kidney Diseases (2) · Male Urogenital Diseases (2) · Pathologic Processes (2) · Pathological Conditions, Signs and Symptoms (2) · Renal Insufficiency (2) · Urogenital Diseases (2)
Atorvastatin (1) · Pravastatin (1) · Valsartan (1) · evolocumab (1)
Duke University (1) · Gachon University Gil Medical Center (1) · NYU Langone Health (1)
South Korea (1) · United States (1)
David Charytan, MD (1) · Lynda Szczech, MD (1)